A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders
| CAGE Code | 61YL4 |
|---|---|
| Legal Name | PhaseBio Pharmaceuticals, Inc. |
| Company Operating Status | Active |
| Full Address | 1 Great Valley Parkway, Suite 30, Malvern, PA 19355, US |
| Previous Name | DT BIOSCIENCES INC |
| Public/Private | Public |
| Stock Symbol | PHAS |
| Ticker Symbol | PHAS |
| Wellfound ID | phasebio-pharmaceuticals |
Email and phone for PhaseBio Pharmaceuticals are available to signed-in members of CliffBio.
Sign in to view